Two Sigma Investments LP Buys 37,772 Shares of Arteris, Inc. (NASDAQ:AIP)

Two Sigma Investments LP grew its stake in Arteris, Inc. (NASDAQ:AIP - Free Report) by 166.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,533 shares of the company's stock after purchasing an additional 37,772 shares during the period. Two Sigma Investments LP owned approximately 0.15% of Arteris worth $617,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Quarry LP acquired a new position in shares of Arteris in the 4th quarter worth approximately $46,000. US Bancorp DE boosted its holdings in shares of Arteris by 29.0% in the 4th quarter. US Bancorp DE now owns 5,702 shares of the company's stock worth $58,000 after acquiring an additional 1,283 shares in the last quarter. D. E. Shaw & Co. Inc. acquired a new position in shares of Arteris in the 4th quarter worth approximately $110,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Arteris in the 4th quarter worth approximately $117,000. Finally, SG Americas Securities LLC acquired a new position in shares of Arteris in the 4th quarter worth approximately $134,000. 64.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Rosenblatt Securities reissued a "buy" rating and issued a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st. Northland Securities boosted their target price on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Wednesday, February 19th.

Insiders Place Their Bets

In other Arteris news, COO Laurent R. Moll sold 4,703 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total transaction of $33,485.36. Following the completion of the sale, the chief operating officer now owns 482,833 shares in the company, valued at approximately $3,437,770.96. The trade was a 0.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Nicholas B. Hawkins sold 3,888 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total transaction of $27,682.56. Following the sale, the chief financial officer now owns 181,545 shares of the company's stock, valued at $1,292,600.40. The trade was a 2.10% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 47,125 shares of company stock valued at $334,886. 29.10% of the stock is currently owned by corporate insiders.

Arteris Stock Up 3.7%

NASDAQ:AIP opened at $7.93 on Monday. The stock's fifty day moving average price is $6.88 and its two-hundred day moving average price is $8.60. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $12.64. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. The company has a market cap of $332.89 million, a price-to-earnings ratio of -9.11 and a beta of 1.37.

Arteris Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.